Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Kelowna, British Columbia, Canada
SEC filing record 1 source field available
Fiscal year end
31 August
Lexaria Bioscience Corp. has filed 1,088 SEC EDGAR filings since 01 Mar 2006

SEC filing history

Showing 101-125 of 964 matching filings.

Per page
25
Current page
5
4

PRIMARY DOCUMENT

Filing date
10 May 2024
Reporting date
26 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 May 2024
Reporting date
26 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 May 2024
Reporting date
26 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-512223

D filing

Filing date
02 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-85256

SCHEDULE 13D/A

Filing date
25 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-277863

EFFECT filing

Filing date
20 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-277863

FORM 424B3

Filing date
20 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
18 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-277863

UPLOAD filing

Filing date
18 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
15 Mar 2024
Reporting date
14 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-277863

FORM S-1

Filing date
12 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39874

DEF 14A

Filing date
06 Mar 2024
Reporting date
27 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-505502

D filing

Filing date
16 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-262402

424B5

Filing date
16 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-85256

SCHEDULE 13D-A

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85256

AMENDMENT NO. 2

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-271096

EFFECT filing

Filing date
26 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .